Aegon Ltd. New York Registry Shares (AEG) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-02, Aegon Ltd. New York Registry Shares (NYSE: AEG) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $8.18 (-1.45% 1D, market cap $14.94B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 12/20. Across 1096 tracked Financials issuers, AEG ranks #596 in composite RQD confidence.
Within the Financials sector (Life Insurance), AEG carries a Roarable D+ (53/100 RQD), trailing P/E of 32.8x, gross margin of —, and ROIC of 9.9%. By comparison, CRBG (Corebridge Financial Inc.) holds a C grade (62/100 RQD, P/E N/A, ROIC -0.3%, cap $15.73B) and RGA (Reinsurance Group of America Incorporated) posts a C+ grade (69/100 RQD, P/E 14.6x, ROIC 1.6%, cap $17.20B). Among the 5-stock peer group, GL leads on earnings multiple (10.6x) while GL leads on capital efficiency (24.3% ROIC).
For Aegon Ltd. New York Registry Shares (AEG), key quantitative strengths include Clean SEC annual filing review with no major hidden accounting time-bombs. and sector rank #596 in Financials, while primary risk factors center on Sensitive to high interest rates and tighter Federal Reserve market liquidity. and implied 5-year growth hurdle of 25.3%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
SEC Form 4 / 13F Thermometer: 60% Net Buy • Cannibal Buyback (-1.24% YoY Shares)
Macro rate sensitivity & RSI-14 (45.3) create a -14 pt regime headwind
While AEG currently carries a cautious 53/100 (D+) rating due to Macro Regime Fit (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Clean SEC annual filing review with no major hidden accounting time-bombs.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($8.68) and Max Pain ($8.59) forces dealer call-delta covering toward $10.09.
Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-1.24% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Aegon Ltd. New York Registry Shares (AEG) slipped -1.45% to $8.18, trading at 50% of its 52-week range ($6.75 – $9.61). Stretched risk/reward at 33x P/E (10% return on capital) under elevated 10-year interest-rate pressure.
Aegon has delivered a strong 5 year share price run, which puts fresh focus on a simple question for anyone looking at the stock today: Is the current market value properly aligned with what the insurer actually earns? O
Schiphol, October 15, 2026 - Aegon today announces that it has repurchased all outstanding Common Shares B held by its largest shareholder, Vereniging Aegon Americas, in exchange for common shares with equal voting right
Aegon (ENXTAM:AGN) stays in focus after investors reviewed fresh return data alongside its broad insurance footprint across the Americas, the Netherlands, the United Kingdom and other markets, putting recent share perfor
Aegon has delivered a powerful 5 year run, yet the recent pullback leaves a clear question on the table for investors who care about what they are paying for each euro of earnings. With the stock now around €7.39 and cor
Aegon (NYSE:AEG) shareholders approved a proposal to re-domicile the insurer to the United States, where the company plans to operate as Transamerica Inc. The extraordinary general meeting also approved an omnibus equity
Schiphol, October 8, 2026 - Aegon Ltd.’s Extraordinary General Meeting of Shareholders (EGM) today approved both the Redomiciliation and the Omnibus Incentive Plan proposal, giving Aegon the mandate to proceed with its r
Aegon (ENXTAM:AGN) has drawn fresh attention after its recent trading session, with the share price closing at €7.83. Investors are weighing this level against the insurer’s recent returns and valuation metrics. Recent t
Schiphol, August 26, 2026 - Aegon announces that it has filed with the U.S. Securities and Exchange Commission (SEC) today its registration statement on Form F-4 (Shareholder Circular) in connection with its upcoming Ext
Aegon Ltd. (NYSE:AEG) delivered a stronger argument for its American pivot after first-half operating capital generation, after holding funding and operating expenses, reached €416 million, ahead of the €376 million medi
AEG expands its 2026 buyback by EUR 150 million as strong profits, capital generation and cash flow support returns.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -2.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on AEG today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for AEG. Explore sector supply chains on /butterfly.
Across 1096 tracked Financials securities in the Roarable RQD universe, Aegon Ltd. New York Registry Shares (AEG) ranks #596 by composite RQD confidence (53/100, grade D+) and #137 by equity capitalization ($14.94B). Within this direct 5-issuer industry benchmark cohort, GL leads on earnings valuation at 10.6x trailing P/E, while GL leads on capital efficiency and profitability with 24.3% ROIC and — gross margin. GL currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with AEG at 53/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| AEG
ACTIVE
Aegon Ltd. New York Registry Shares | D+ | 53/100 | 32.8x | — | 9.9% | -1.45% | $14.94B | Benchmark Subject |
| CRBG Corebridge Financial Inc. | C | 62/100 | — | — | -0.3% | -1.36% | $15.73B | /crbg-vs-aeg → |
| RGA Reinsurance Group of America Incorporated | C+ | 69/100 | 14.6x | — | 1.6% | +0.49% | $17.20B | /rga-vs-aeg → |
| GL Globe Life Inc. | B- | 71/100 | 10.6x | — | 24.3% | -0.85% | $12.33B | /gl-vs-aeg → |
| JXN Jackson Financial Inc. (Class A) | C- | 61/100 | — | — | 0.0% | -0.76% | $9.21B | /jxn-vs-aeg → |
Aegon Ltd. New York Registry Shares (AEG) operates in Life Insurance (Financials) with an equity capitalization of $14.94B, trailing P/E of 32.8x, forward P/E of 30.5x, and EV/EBITDA of 21.0x. Operating profitability registers a gross margin of —, operating margin of 13.9%, net profit margin of 10.9%, ROIC of 9.9%, and free cash flow yield of 2.21%, alongside an Altman Z-Score of N/A and Piotroski F-Score of 7/9.
As of 2026-11-02, Aegon Ltd. New York Registry Shares (NYSE: AEG) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $8.18 (-1.45% 1D, market cap $14.94B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 12/20. Across 1096 tracked Financials issuers, AEG ranks #596 in composite RQD confidence.
Within the Financials sector (Life Insurance), AEG carries a Roarable D+ (53/100 RQD), trailing P/E of 32.8x, gross margin of —, and ROIC of 9.9%. By comparison, CRBG (Corebridge Financial Inc.) holds a C grade (62/100 RQD, P/E N/A, ROIC -0.3%, cap $15.73B) and RGA (Reinsurance Group of America Incorporated) posts a C+ grade (69/100 RQD, P/E 14.6x, ROIC 1.6%, cap $17.20B). Among the 5-stock peer group, GL leads on earnings multiple (10.6x) while GL leads on capital efficiency (24.3% ROIC).
For Aegon Ltd. New York Registry Shares (AEG), key quantitative strengths include Clean SEC annual filing review with no major hidden accounting time-bombs. and sector rank #596 in Financials, while primary risk factors center on Sensitive to high interest rates and tighter Federal Reserve market liquidity. and implied 5-year growth hurdle of 25.3%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
AEG last traded at $8.18 (-1.45% on volume of 4,391,839 shares), positioning the stock -5.76% below its 50-day simple moving average ($8.68) and -1.56% below its 200-day simple moving average ($8.31). Across its 52-week range of $6.75 to $9.61, AEG sits at the 50.0% percentile with a 14-day RSI of 45.3 (NEUTRAL RANGE) and an implied next-earnings move of ±2.3% ($7.99 to $8.37).
Why AEG Stock slipped -1.45% Today — RQD Quant Desk Flash. Stretched risk/reward at 33x P/E (10% return on capital) under elevated 10-year interest-rate pressure.
Per the Roarable RQD rating, AEG scores 53 out of 100, a letter grade of D+, with the verdict "Roarable Sell — Weak Fundamentals / Trim." The five pillars are scored as follows:
Taken together, the rating points to a stock whose balance sheet is its most supportive attribute while its macro fit and institutional flow signals are weak. For a prospective investor evaluating the stock today, the market data shows a trailing P/E of 32.8 and an EV/EBITDA of 21, which are elevated valuation multiples relative to the modest ROIC and FCF yield. The upside case rests on balance-sheet durability and any improvement in cash generation; the valuation tradeoff is that the current multiples leave limited margin for disappointment.
Aegon Ltd. New York Registry Shares (AEG) is a NYSE-listed issuer in the Financials sector, operating within the Life Insurance industry, per the company profile. Per the profile, the company carries a market capitalization of $14.9B. Business description, customer base, and revenue model details are not available in source data.
Per the Butterfly Supply-Chain Graph, the supply chain is recorded as "NONE," with no butterfly links and no proprietary signals. Upstream and downstream dependencies, sector correlations beyond the stated Financials / Life Insurance classification, and second-order bottlenecks are not available in source data.
Real-time company headlines, analyst actions, and sector developments for Aegon Ltd. New York Registry Shares (AEG) • Click "Debate This Headline" to argue it in the Roar Pit below
Aegon has delivered a strong 5 year share price run, which puts fresh focus on a simple question for anyone looking at the stock today: Is the current market value properly aligned with what the insurer actually earns? O
Schiphol, October 15, 2026 - Aegon today announces that it has repurchased all outstanding Common Shares B held by its largest shareholder, Vereniging Aegon Americas, in exchange for common shares with equal voting right
Aegon (ENXTAM:AGN) stays in focus after investors reviewed fresh return data alongside its broad insurance footprint across the Americas, the Netherlands, the United Kingdom and other markets, putting recent share perfor
Aegon has delivered a powerful 5 year run, yet the recent pullback leaves a clear question on the table for investors who care about what they are paying for each euro of earnings. With the stock now around €7.39 and cor
Aegon (NYSE:AEG) shareholders approved a proposal to re-domicile the insurer to the United States, where the company plans to operate as Transamerica Inc. The extraordinary general meeting also approved an omnibus equity
Schiphol, October 8, 2026 - Aegon Ltd.’s Extraordinary General Meeting of Shareholders (EGM) today approved both the Redomiciliation and the Omnibus Incentive Plan proposal, giving Aegon the mandate to proceed with its r
Aegon (ENXTAM:AGN) has drawn fresh attention after its recent trading session, with the share price closing at €7.83. Investors are weighing this level against the insurer’s recent returns and valuation metrics. Recent t
Schiphol, August 26, 2026 - Aegon announces that it has filed with the U.S. Securities and Exchange Commission (SEC) today its registration statement on Form F-4 (Shareholder Circular) in connection with its upcoming Ext
Welcome to the AEG (Aegon Ltd. New York Registry Shares) Roar Pit. Current RQD Composite is 53/100 (Roarable Sell — Weak Fundamentals / Trim) in Life Insurance. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (32.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Everyone in here is repeating the bull case on AEG, but look at what you are paying: 32.8x trailing P/E with tightening sector spreads. Unless Aegon Ltd. New York Registry Shares expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
Looking at the 5-pillar RQD breakdown on AEG, the market is fixating on short-term headline noise in Life Insurance and ignoring the balance sheet and cash flow trajectory. At $8.30 (52-wk range $6.75 - $9.61), any beat on forward guidance forces shorts and underweight funds to chase.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).